26 results
D
INM
InMed Pharmaceuticals Inc
5 Dec 22
$6.00 mm in equity / options, sold $6.00 mm, 2 investors
7:25pm
or Other Right to Acquire Another Security
Mineral Property Securities
Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire
D
INM
InMed Pharmaceuticals Inc
8 Jun 22
$5M in equity / options, sold $5M, 1 investor
2:26pm
or Other Right to Acquire Another Security
Mineral Property Securities
Security to be Acquired Upon Exercise of Option, Warrant or Other Right
424B5
INM
InMed Pharmaceuticals Inc
3 Jun 22
Prospectus supplement for primary offering
9:45pm
on mineral oil. Until very recently, studies on novel topical ophthalmic formulations of cannabinoids have been largely non-existent. Nevertheless
424B3
INM
InMed Pharmaceuticals Inc
25 Apr 22
Prospectus supplement
5:02pm
, in particular, the intoxicating drug THC, to the ocular tissues used formulations based on mineral oil. Until very recently, studies on novel topical
424B3
9khajjy04n03pcyd34ax
7 Apr 22
Prospectus supplement
4:46pm
S-3
fdgwwzys2gt
4 Feb 22
Shelf registration
4:36pm
D
ruxf7ch
28 Oct 21
$4.31M in equity, sold $4.31M, 54 investors
11:29am
8-K
EX-2.1
c1hhw9rcot6 0h
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
lgq1mtuf
24 Sep 21
Annual report
7:31am
10-K
EX-2.1
tja 5lw75m5u5
24 Sep 21
Annual report
7:31am
424B3
6y4y3wl
22 Jul 21
Prospectus supplement
10:27am
D
rci360pti 240g
19 Jul 21
$12M in equity / options, sold $12M, 1 investor
6:13am
424B3
8aykarg
16 Mar 21
Prospectus supplement
12:00am
424B4
35txkr76uw 9jyxrgx
13 Nov 20
Prospectus supplement with pricing info
8:52pm